GSK To Sell Two Vaccines in $1.1 Billion Deal To Focus On Newer Treatments
Posted by
www.biotecnika.org
GSK to sell two vaccines to Bavarian-Nordic GlaxoSmithKline will sell
2 travel vaccines to Bavarian Nordic for up to 955 million euros i.e,
$1.1 billion, the British firm said on Monday, as it looks to bolster
its push into the lucrative cancer drug market. The sale of
anti-rabies treatment Rabipur & Encepur, used for the […]
The post GSK To Sell Two Vaccines in $1.1 Billion Deal To Focus On
Newer Treatments appeared first on Rasayanika .
https://www.rasayanika.com/2019/11/06/gsk-to-sell-two-vaccines-to-bavarian-nordic-rasayanika-news/
News
Subscribe to:
Post Comments (Atom)
Post a Comment